Journal of bacteriology 2006,188(8):2945–2958.PubMedCrossRef 35. Sabina J, Dover N, Templeton LJ, Smulski DR, Soll D, LaRossa RA: Interfering with different steps of protein synthesis explored by transcriptional profiling of Escherichia
coli K-12. Journal of bacteriology 2003,185(20):6158–6170.PubMedCrossRef 36. Kuznetsova E, Proudfoot M, Gonzalez CF, Brown G, Omelchenko MV, Borozan I, Carmel L, Wolf YI, Mori H, Savchenko AV, et al.: Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family. The Journal of biological chemistry 2006,281(47):36149–36161.PubMedCrossRef 37. Zhao K, Liu M, Burgess RR: The Global Transcriptional Response of Escherichia coli to Induced σ 32 Protein Involves σ 32 Regulon Activation Followed by Inactivation and Degradation of σ 32 in vivo . The Journal of biological chemistry 2005,280(18):17758–17768.PubMedCrossRef selleck chemicals llc selleck 38. Wang X, Zhao X: Contribution of oxidative damage to antimicrobial lethality. Antimicrobial agents and chemotherapy 2009,53(4):1395–1402.PubMedCrossRef 39. Malik M, Capecci J, Drlica K: Lon protease is essential for paradoxical survival of Escherichia coli exposed to high concentrations of quinolone.
Antimicrobial agents and chemotherapy 2009,53(7):3103–3105.PubMedCrossRef Authors’ contributions XH screened for hypersusceptible mutants, helped identifying insertion sites, and measured susceptibility of mutants Resminostat to antimicrobial agents and other stresses. AD participated in writing the manuscript. MM participated in mutant screening. JW identified genes containing Tn5 insertions. KD participated in initial project design, supervised all work performed at PHRI, and participated in writing the manuscript. XZ participated in project design, screened for mutants, and participated in writing the manuscript. TL participated in initial project design, supervised all work performed at YNU, constructed the insertion library, screened for mutants, carried out
P1-transduction, and carried out primary writing of manuscript. All authors read and approved the final manuscript.”
“Background Streptococcus pyogenes (group A streptococcus, GAS) is an important and exclusively human pathogen, which causes a variety of diseases ranging from mild superficial infections to invasive life-threatening illnesses with high mortality rates [1–4]. Successful colonization and persistence Selleck Necrostatin-1 within the host relies on sensing and responding to the changes in the environmental conditions. These responses are very often mediated by two-component signal transduction regulatory systems (TCS). The CovRS (also called CsrRS, [5]) system is one of 13 TCS in the GAS genome, which has been extensively studied, and for which a central role in growth and pathogenesis was found [6–8]. CovR represses either directly or indirectly about 15% of the genes in GAS [9–11], many of which represent important virulence factors.